Form 4: American Oncology Network Director Acquires Shares as Part of Compensation

Bradley M. Fluegel, a director of American Oncology Network, Inc., acquired 14,981 shares of Class A Common Stock on May 4, 2024, as compensation for his service on the board.

Summary

• On May 4, 2024, Bradley M. Fluegel, a director of American Oncology Network, Inc. (AONC), acquired 14,981 shares of Class A Common Stock.
• The acquisition was a grant for service as an independent director on the American Oncology Network, Inc. Board of Directors.
• These shares will vest on May 4, 2025.
• Following the transaction, Fluegel directly owns 39,981 shares of Class A Common Stock.

Sentiment

Score: 7

Explanation: The sentiment is neutral to positive. The director's acquisition of shares as part of their compensation package is a standard practice and indicates alignment with the company's interests.

Positives

• The acquisition of shares by a director demonstrates alignment with the company's interests.
• The vesting schedule incentivizes continued service and commitment to the board.

Industry Context

Director share acquisitions are common in publicly traded companies as a form of compensation and to align the interests of directors with those of shareholders.

Stakeholder Impact

• The acquisition of shares by a director can positively influence shareholder confidence.

Key Dates

Keywords

AONC, American Oncology Network, Director, Share Acquisition, Form 4, Beneficial Ownership, Compensation, Class A Common Stock